Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Ipca Labs gets 3 USFDA observations for Piparia facility

Ruchika Sharma27 April 2023 11:15 AM IST

Mumbai: Ipca Laboratories has recently announced that the US Food and Drug Administration (USFDA) has issued a Form 483 with 3 observations at the...

Abbotts Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe Widens

Abbott India recalls batch of thyroid drug Thyronorm over labeling error, details

Ruchika Sharma26 April 2023 5:10 PM IST

Mumbai: Abbott India Ltd. has recently informed through a public notice that the company has issued a voluntary recall of one batch of Thyronorm...

Glenmark to settle US lawsuits over generic drug for over Rs 715 crore

Ruchika Sharma26 April 2023 4:28 PM IST

The settlements will make clear that the company denies each and every one of the allegations against it and the settlements are not on the basis of...

GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline

GSK Shingles vaccine Shingrix now in India

Ruchika Sharma26 April 2023 3:27 PM IST

Shingrix is a non-live vaccine it can be offered to those, above the age of 50 years, who are immunocompromised and/or immunosuppressed and who are...

"Someone duplicated cough syrup to defame India": QP Pharma Chem MD after WHO issues alert

Ruchika Sharma26 April 2023 1:30 PM IST

According to the WHO report, the Guaifenesin Syrup TG Syrup was found with unacceptable amounts of contaminants of diethylene glycol and ethylene...

IVF specialist moves Delhi HC against blanket ban on frozen embryo adoption, court seeks centres response

Delhi HC permits Daiichi Sankyo to withdraw over Rs 20.5 crore deposited with court

Ruchika Sharma26 April 2023 12:30 PM IST

New Delhi: The Delhi High Court Monday permitted Japanese pharma major Daiichi Sankyo to withdraw over Rs 20.5 crore which was transmitted to the high...

Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution

Fosun Pharma withdraws plans to sell stake in Gland Pharma

Ruchika Sharma26 April 2023 11:37 AM IST

Bengaluru: China's Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd, ET Now...

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Zydus Lifesciences bags USFDA nod for Metronidazole topical cream to treat skin disorder

Ruchika Sharma25 April 2023 5:15 PM IST

The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad, India.

Philips makes USD 631 million provision for recall litigation costs

Ruchika Sharma25 April 2023 4:00 PM IST

Amsterdam: Philips, a Dutch health technology company on Monday said it had set aside 575 million euros ($631 million) for possible litigation costs...

USFDA nod to JnJ Tremfya for Crohns disease

JnJ seeks valuation of up to USD 43 billion in IPO of consumer health unit Kenvue

Ruchika Sharma25 April 2023 2:46 PM IST

New Jersey: Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initial public offering of its...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Ipca Labs to buy 33 percent stake in Unichem Labs for 1,034 crore

Ruchika Sharma25 April 2023 1:30 PM IST

These transactions are subject to approval of the Competition Commission of India under the Competition Act, 2002 and such other approvals as may be...

Serum Institute of Life Sciences to double investment in Biocon unit to Rs 2457 crore

Ruchika Sharma25 April 2023 12:30 PM IST

Under new terms of the alliance, it would pump in USD 150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok